UniProt/SwissProt ID: | NR2C2_HUMAN |
Description: | nuclear receptor subfamily 2, group C, member 2 [Source:HGNC Symbol;Acc:7972] |
Location: | chr3 p25.1 |
Node attribute: | kinase |
Phosphorylation site |
Position | PhosphoPeptide | Catalytic kinase | Source |
---|---|---|---|
S46 | VDASGsPKQQF | PhosphoSitePlus | |
S117 | VTDSAsVERLL | HPRD | |
T224 | SPLIAtPTFVA | PhosphoSitePlus; phosphoELM | |
T13 | IQIIStDSAVA | HPRD | |
S238 | RKDLRsPLIAT | HPRD | |
T352 | SRDQStPIIEV | PhosphoSitePlus | |
S351 | ISRDQsTPIIE | PhosphoSitePlus | |
T243 | SPLIAtPTFVA | HPRD | |
S12 | RIQIIsTDSAV | HPRD | |
T371 | SRDQStPIIEV | HPRD | |
S68 | KVILAsPETSS | PhosphoSitePlus | |
S98 | VTDSAsVERLL | PhosphoSitePlus | |
Y116 | PQVVEyCVVCG | zf-C4 | PhosphoSitePlus |
S219 | RKDLRsPLIAT | PhosphoSitePlus; phosphoELM | |
S19 | DSAVAsPQRIQ | PhosphoSitePlus; HPRD | |
S65 | VDASGsPKQQF | HPRD | |
S87 | KVILAsPETSS | HPRD | |
T245 | LIATPtFVADK | HPRD | |
S74 | QFILTsPDGAG | HPRD | |
T226 | LIATPtFVADK | PhosphoSitePlus; phosphoELM | |
Dephosphorylation site |
NR2C2_HUMAN do not have dephosphorylation site. |
Mutation site |
Ensembl ID | Variation | Source | Cancer name | Pubmed |
---|---|---|---|---|
ENSP00000320447 | D251G | COSMIC | Head and Neck Cancer | 21798893 |
Differential expressed protein |
NR2C2_HUMAN is not differential expressed protein. |
Hyperphosphorylation site |
NR2C2_HUMAN do not have hyperphosphorylation site. |
Direct Interaction Pair |
Source | Target | Relationship | Resource |
---|---|---|---|
NR2C2_HUMAN | M3K7_HUMAN | kinase -> substrate | RegPhos |
NR2C2_HUMAN | SMAD3_HUMAN | kinase -> substrate | RegPhos |
NR2C2_HUMAN | IKKB_HUMAN | kinase -> substrate | RegPhos |
Function Annotation |
KEGG Pathway |
NR2C2_HUMAN is not in KEGG pathway. |
Gene Ontology |
GO ID | GO_Term | Evidence | Ontology |
---|---|---|---|
GO:0004872 | receptor activity | TAS | molecular_function |
GO:0007399 | nervous system development | TAS | biological_process |
GO:0046982 | protein heterodimerization activity | IDA | molecular_function |
GO:0045944 | positive regulation of transcription from RNA poly | IDA | biological_process |
GO:0043565 | sequence-specific DNA binding | IDA | molecular_function |
GO:0008270 | zinc ion binding | IEA | molecular_function |
GO:0005634 | nucleus | IDA | cellular_component |
GO:0040019 | positive regulation of embryonic development | IEA | biological_process |
GO:0007283 | spermatogenesis | IEA | biological_process |
GO:0030154 | cell differentiation | IEA | biological_process |
GO:0043401 | steroid hormone mediated signaling pathway | IEA | biological_process |
GO:0021549 | cerebellum development | IEA | biological_process |
GO:0003713 | transcription coactivator activity | TAS | molecular_function |
GO:0003707 | steroid hormone receptor activity | IEA | molecular_function |
GO:0005515 | protein binding | IEA | molecular_function |
GO:0048520 | positive regulation of behavior | IEA | biological_process |
GO:0005515 | protein binding | IPI | molecular_function |
GO:0051321 | meiotic cell cycle | IEA | biological_process |
GO:0010467 | gene expression | TAS | biological_process |
GO:0006355 | regulation of transcription, DNA-dependent | TAS | biological_process |
GO:0006367 | transcription initiation from RNA polymerase II pr | TAS | biological_process |
GO:0003700 | sequence-specific DNA binding transcription factor | IDA | molecular_function |
GO:0005654 | nucleoplasm | TAS | cellular_component |